Oklahoma 2023 Regular Session

Oklahoma Senate Bill SB227

Introduced
2/6/23  

Caption

Practice of pharmacy; prohibiting certain acts by wholesale distributor except under certain conditions. Effective date.

Impact

The bill's implications extend notably to the powers and responsibilities of pharmacists and wholesale distributors alike. It stipulates that a pharmacy cannot resell dangerous drugs to any wholesale distributor and prohibits wholesale distributors from purchasing drugs from pharmacies, thus aiming to control the flow of pharmaceuticals. Furthermore, the bill establishes stricter rules concerning who may manage a pharmacy, mandating that only licensed pharmacists can oversee pharmacy operations, which aims to ensure compliance with professional standards and enhance drug safety.

Summary

Senate Bill 227 addresses several unlawful acts related to pharmacy practice and the distribution of prescription medications in Oklahoma. It primarily amends existing statutes by defining acts by wholesale distributors that may be deemed unlawful unless certain conditions are met. The bill reinforces existing regulations and introduces new constraints on pharmaceutical practices, aiming to promote professional integrity within the pharmacy sector.

Contention

One notable point of contention surrounding SB227 may involve concerns about the potential impact on pharmacies and their operations. On one hand, proponents argue that the bill is necessary to mitigate malpractice and ensure a higher standard of care in pharmaceutical practice. However, critics may view the bill as excessively stringent, potentially limiting the operational flexibility of pharmacies and increasing the burden on healthcare providers, particularly in how they manage patient prescriptions and deliveries.

Companion Bills

No companion bills found.

Similar Bills

CA AB458

Importation of prescription drugs.

CA SB1361

Prescription drugs: cost sharing: pharmacy benefit managers.

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.

HI SB319

Relating To Prescription Drugs.

HI HB14

Relating To Prescription Drugs.

NV AB110

Makes revisions governing the dispensing and delivery of certain dialysate drugs and devices used to perform dialysis. (BDR 54-616)

WV HB4324

To update collaborative pharmacy practice agreements

MS SB2733

Pharmaceuticals; authorize the Division of Medicaid to establish a wholesale prescription drug importation program.